Application no. and date | 11808359.1 (espacenet) (Federated) (European Patent Register), 20111115 | Patent/reg. no. and date | DK/EP 2640358, 20180103 | Publication date | 20130925 | Priority no. and date | US 413637 P, 20101115, US 201161524064 P, 20110816 | EP pub. no. and date |
EP 2640358 20130925 | Effective date | | Applicant/owner | Neuroderm Ltd, Weizmann Science Park 3 Golda Meir Street
74036 Ness Ziona, IL | Applicant ref. no. | LU-PV-275061/EP-DK-ACT | Inventor | YACOBY-ZEEVI, Oron, 204 Hanarkissim Street
60946 Bitsaron, IL, NEMAS, Mara, 17/4 Ha'atsmaut Street
70700 Gedera, IL | Representative | Dennemeyer & Associates S.A, P.O. Box 700425
DE-81304 Munich, DE | Opponent | | IPC Class | A61K 31/195 (2006.01) , A61K 31/198 (2006.01) , A61K 9/08 (2006.01) , A61P 25/16 (2006.01) | Title | KONTINUERLIG ADMINISTRATION AF L-DOPA, DOPA-DECARBOXYLASE-INHIBITORER, CATECHOL-O-METHYL-TRANSFERASE-INHIBITORER OG SAMMENSÆTNINGER DERTIL | Int. application no. | IL2011000881 | Int. publication no. | WO2012066538 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|